Mental health disorders continue to impose a significant burden on patients, families, and healthcare systems worldwide. Effective management requires therapies that can address a broad spectrum of symptoms while maintaining good tolerability.
Quetiapine is a globally recognized atypical antipsychotic with proven efficacy in the management of psychotic and mood disorders. Ariquet has been introduced to provide healthcare professionals with a reliable treatment option backed by the established clinical benefits of Quetiapine. The product is available in 25 mg, 50 mg Extended Release (ER), and 100 mg strengths to facilitate individualized treatment approaches. Its flexible dosing options support both initiation and maintenance phases of therapy. Quetiapine's balanced action on dopamine and serotonin receptors contributes to symptom control and mood stabilization.
FR
DE